PortfoliosLab logoPortfoliosLab logo
PGNY vs. XP
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

PGNY vs. XP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Progyny, Inc. (PGNY) and XP Inc. (XP). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

PGNY vs. XP - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
PGNY
Progyny, Inc.
-34.35%48.87%-53.60%19.36%-38.13%18.78%54.43%3.74%
XP
XP Inc.
14.29%39.53%-52.23%79.63%-46.62%-27.55%2.99%11.78%

Fundamentals

Market Cap

PGNY:

$1.51B

XP:

$9.73B

EPS

PGNY:

$0.65

XP:

$9.75

PE Ratio

PGNY:

25.87

XP:

1.92

PEG Ratio

PGNY:

2.10

XP:

0.17

PS Ratio

PGNY:

1.17

XP:

0.55

PB Ratio

PGNY:

2.92

XP:

0.41

Total Revenue (TTM)

PGNY:

$1.29B

XP:

$18.03B

Gross Profit (TTM)

PGNY:

$304.48M

XP:

$7.23B

EBITDA (TTM)

PGNY:

$94.01M

XP:

$6.33B

Returns By Period

In the year-to-date period, PGNY achieves a -34.35% return, which is significantly lower than XP's 14.29% return.


PGNY

1D
-0.71%
1M
-4.20%
YTD
-34.35%
6M
-20.55%
1Y
-26.98%
3Y*
-19.33%
5Y*
-18.06%
10Y*

XP

1D
-1.73%
1M
-13.82%
YTD
14.29%
6M
3.67%
1Y
33.56%
3Y*
20.93%
5Y*
-11.96%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PGNY vs. XP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PGNY
PGNY Risk / Return Rank: 1616
Overall Rank
PGNY Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
PGNY Sortino Ratio Rank: 1818
Sortino Ratio Rank
PGNY Omega Ratio Rank: 1818
Omega Ratio Rank
PGNY Calmar Ratio Rank: 2020
Calmar Ratio Rank
PGNY Martin Ratio Rank: 88
Martin Ratio Rank

XP
XP Risk / Return Rank: 6565
Overall Rank
XP Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
XP Sortino Ratio Rank: 6161
Sortino Ratio Rank
XP Omega Ratio Rank: 6060
Omega Ratio Rank
XP Calmar Ratio Rank: 7171
Calmar Ratio Rank
XP Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PGNY vs. XP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Progyny, Inc. (PGNY) and XP Inc. (XP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PGNYXPDifference

Sharpe ratio

Return per unit of total volatility

-0.52

0.74

-1.26

Sortino ratio

Return per unit of downside risk

-0.50

1.27

-1.77

Omega ratio

Gain probability vs. loss probability

0.93

1.16

-0.23

Calmar ratio

Return relative to maximum drawdown

-0.60

1.61

-2.21

Martin ratio

Return relative to average drawdown

-1.54

3.01

-4.55

PGNY vs. XP - Sharpe Ratio Comparison

The current PGNY Sharpe Ratio is -0.52, which is lower than the XP Sharpe Ratio of 0.74. The chart below compares the historical Sharpe Ratios of PGNY and XP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


PGNYXPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.52

0.74

-1.26

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.33

-0.24

-0.09

Sharpe Ratio (All Time)

Calculated using the full available price history

0.01

-0.13

+0.15

Correlation

The correlation between PGNY and XP is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

PGNY vs. XP - Dividend Comparison

PGNY has not paid dividends to shareholders, while XP's dividend yield for the trailing twelve months is around 0.96%.


TTM202520242023
PGNY
Progyny, Inc.
0.00%0.00%0.00%0.00%
XP
XP Inc.
0.96%1.10%5.49%5.02%

Drawdowns

PGNY vs. XP - Drawdown Comparison

The maximum PGNY drawdown since its inception was -79.49%, roughly equal to the maximum XP drawdown of -79.19%. Use the drawdown chart below to compare losses from any high point for PGNY and XP.


Loading graphics...

Drawdown Indicators


PGNYXPDifference

Max Drawdown

Largest peak-to-trough decline

-79.49%

-79.19%

-0.30%

Max Drawdown (1Y)

Largest decline over 1 year

-40.68%

-23.33%

-17.35%

Max Drawdown (5Y)

Largest decline over 5 years

-79.49%

-79.19%

-0.30%

Current Drawdown

Current decline from peak

-74.71%

-58.98%

-15.73%

Average Drawdown

Average peak-to-trough decline

-41.67%

-46.63%

+4.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.91%

12.45%

+3.46%

Volatility

PGNY vs. XP - Volatility Comparison

The current volatility for Progyny, Inc. (PGNY) is 7.85%, while XP Inc. (XP) has a volatility of 20.81%. This indicates that PGNY experiences smaller price fluctuations and is considered to be less risky than XP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


PGNYXPDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.85%

20.81%

-12.96%

Volatility (6M)

Calculated over the trailing 6-month period

43.44%

35.98%

+7.46%

Volatility (1Y)

Calculated over the trailing 1-year period

52.03%

45.65%

+6.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

55.34%

49.61%

+5.73%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

61.74%

57.67%

+4.07%

Financials

PGNY vs. XP - Financials Comparison

This section allows you to compare key financial metrics between Progyny, Inc. and XP Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
318.40M
4.81B
(PGNY) Total Revenue
(XP) Total Revenue
Values in USD except per share items

PGNY vs. XP - Profitability Comparison

The chart below illustrates the profitability comparison between Progyny, Inc. and XP Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
24.2%
71.0%
Portfolio components
PGNY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Progyny, Inc. reported a gross profit of 76.88M and revenue of 318.40M. Therefore, the gross margin over that period was 24.2%.

XP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, XP Inc. reported a gross profit of 3.41B and revenue of 4.81B. Therefore, the gross margin over that period was 71.0%.

PGNY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Progyny, Inc. reported an operating income of 15.22M and revenue of 318.40M, resulting in an operating margin of 4.8%.

XP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, XP Inc. reported an operating income of 2.96B and revenue of 4.81B, resulting in an operating margin of 61.6%.

PGNY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Progyny, Inc. reported a net income of 12.49M and revenue of 318.40M, resulting in a net margin of 3.9%.

XP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, XP Inc. reported a net income of 1.30B and revenue of 4.81B, resulting in a net margin of 27.0%.